FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
CVBF at the ERAMET Kick-Off Meeting
Namur, Belgium - CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was organized by [...]
29 February 2024, Rare Disease Day
29 February is Rare Disease Day, falling on the rarest date of the calendar. This is an opportunity to raise awareness that [...]
CVBF’s Scientific Director to Speak at Rare Disease & Orphan Drugs Congress
Giovanni Migliaccio, Scientific Director of CVBF and member of the Board of Directors of the European Paediatric Translational Research Infrastructure (EPTRI), will [...]
13 Organizations Across Europe Join Forces for Novel ATMP on Faecal incontinence.
CVBF provides regulatory, site management, and monitoring support for the AMELIE (Anchored Muscle cELls for IncontinencE) project, Ana Dilo as [...]
New Article on Gabapentin and Tramadol in Paediatric Patients with Chronic Pain
A new article published on 6 October 2023 in the Journal of the British Pharmacological Society titled"Dose rationale for gabapentin [...]
Quality Assurance Head, Mariagrazia Felisi, Leads Workshop on EU Clinical Trial Regulation
On 27 June 2023, Mariagrazia Felisi, our Quality Assurance Head and Internal Auditor, co-chairing the "AICRO Clinical Trial Center Working [...]
Advanced Therapies: A Researcher’s Perspective on ATMPs – Insights from Giovanni Migliaccio
Giovanni Migliaccio, the Scientific Director of CVBF, recently participated at the MEP Interest Group 2023 Conference organized by the European [...]
CVBF participates in the Smarter Programme For Technological Innovation
Thanks to the close collaboration with Aldo Moro University of Bari, Exprivia spa and Hero srl, and following the agreement signed with the Ministry of University [...]
CVBF September Special Issue
This new Special Issue is dedicated to the active involvement of CVBF in the European Joint Programme for Rare Diseases (EJP RD), a consortium that [...]
Scientific publication: Patient-Reported Outcome Measures in Clinical Research
The “Patient-Reported Outcome Measures in Clinical Research” research paper describes the importance and also some limitations of the use of patient-reported outcome measures (PROMs) in [...]
European Research and Innovation Days 2022
The European Research and Innovation Days will take place online on 28 and 29 September 2022, allowing everyone to get involved from anywhere. This is [...]
Scientific publication: Ensuring a future for gene therapy for rare diseases
The paper “Ensuring a future for gene therapy for rare diseases” by Alessandro Aiuti, Francesca Pasinelli, and Luigi Naldini has been recently published in the [...]
Mitochondrial Diseases Conference 2022
The 2022 Mitochondrial Diseases Conference, organized by Mitocon, will be held on 7th – 9th October at the Holiday Inn Rome EUR Parco dei Medici, [...]












